TY - JOUR AU - Hamers-Casterman, C. AU - Atarhouch, T. AU - Muyldermans, S. AU - Robinson, G. AU - Hamers, C. AU - Songa, E. B. PY - 1993 DA - 1993// TI - Naturally occurring antibodies devoid of light chains JO - Nature VL - 363 UR - https://doi.org/10.1038/363446a0 DO - 10.1038/363446a0 ID - Hamers-Casterman1993 ER - TY - JOUR AU - Revets, H. AU - Baetselier, P. AU - Muyldermans, S. PY - 2005 DA - 2005// TI - Nanobodies as novel agents for cancer therapy JO - Expert opinion on biological therapy VL - 5 UR - https://doi.org/10.1517/14712598.5.1.111 DO - 10.1517/14712598.5.1.111 ID - Revets2005 ER - TY - JOUR AU - Wolfson, W. PY - 2006 DA - 2006// TI - Ablynx makes nanobodies from llama bodies JO - Chem Biol VL - 13 UR - https://doi.org/10.1016/j.chembiol.2006.12.003 DO - 10.1016/j.chembiol.2006.12.003 ID - Wolfson2006 ER - TY - JOUR AU - Muyldermans, S. AU - Atarhouch, T. AU - Saldanha, J. AU - Barbosa, J. A. AU - Hamers, R. PY - 1994 DA - 1994// TI - Sequence and structure of VH domain from naturally occurring camel heavy chain immunoglobulins lacking light chains JO - Protein Eng VL - 7 UR - https://doi.org/10.1093/protein/7.9.1129 DO - 10.1093/protein/7.9.1129 ID - Muyldermans1994 ER - TY - JOUR AU - Lauwereys, M. AU - Arbabi Ghahroudi, M. AU - Desmyter, A. AU - Kinne, J. AU - Holzer, W. AU - Genst, E. PY - 1998 DA - 1998// TI - Potent enzyme inhibitors derived from dromedary heavy-chain antibodies JO - EMBO J VL - 17 UR - https://doi.org/10.1093/emboj/17.13.3512 DO - 10.1093/emboj/17.13.3512 ID - Lauwereys1998 ER - TY - JOUR AU - Mujic-Delic, A. AU - Wit, R. H. AU - Verkaar, F. AU - Smit, M. J. PY - 2014 DA - 2014// TI - GPCR-targeting nanobodies: attractive research tools, diagnostics, and therapeutics JO - Trends Pharmacol Sci VL - 35 UR - https://doi.org/10.1016/j.tips.2014.03.003 DO - 10.1016/j.tips.2014.03.003 ID - Mujic-Delic2014 ER - TY - JOUR AU - Audenhove, I. AU - Gettemans, J. PY - 2016 DA - 2016// TI - Nanobodies as versatile tools to understand, diagnose, visualize and treat cancer JO - EBioMedicine VL - 8 UR - https://doi.org/10.1016/j.ebiom.2016.04.028 DO - 10.1016/j.ebiom.2016.04.028 ID - Audenhove2016 ER - TY - STD TI - Oliveira S, Heukers R, Sornkom J, Kok RJ, van Bergen En Henegouwen PM. Targeting tumors with nanobodies for cancer imaging and therapy. J Controlled Release. 2013;172(3):607–17. ID - ref8 ER - TY - JOUR AU - Ingram, J. R. AU - Schmidt, F. I. AU - Ploegh, H. L. PY - 2018 DA - 2018// TI - Exploiting nanobodies' singular traits JO - Annu Rev Immunol VL - 36 UR - https://doi.org/10.1146/annurev-immunol-042617-053327 DO - 10.1146/annurev-immunol-042617-053327 ID - Ingram2018 ER - TY - JOUR AU - Senders, M. L. AU - Hernot, S. AU - Carlucci, G. AU - Voort, J. C. AU - Fay, F. AU - Calcagno, C. PY - 2019 DA - 2019// TI - Nanobody-facilitated multiparametric PET/MRI phenotyping of atherosclerosis JO - JACC Cardiovas Imaging VL - 12 UR - https://doi.org/10.1016/j.jcmg.2018.07.027 DO - 10.1016/j.jcmg.2018.07.027 ID - Senders2019 ER - TY - JOUR AU - Debie, P. AU - Lafont, C. AU - Defrise, M. AU - Hansen, I. AU - Willigen, D. M. AU - Leeuwen, F. W. B. PY - 2020 DA - 2020// TI - Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours JO - J Controlled Release VL - 317 UR - https://doi.org/10.1016/j.jconrel.2019.11.014 DO - 10.1016/j.jconrel.2019.11.014 ID - Debie2020 ER - TY - STD TI - Rossotti MA, González-Techera A, Guarnaschelli J, Yim L, Camacho X, Fernández M, et al. Increasing the potency of neutralizing single-domain antibodies by functionalization with a CD11b/CD18 binding domain. mAbs. 2015;7(5):820–8. ID - ref12 ER - TY - JOUR AU - Vaneycken, I. AU - D'Huyvetter, M. AU - Hernot, S. AU - Vos, J. AU - Xavier, C. AU - Devoogdt, N. PY - 2011 DA - 2011// TI - Immuno-imaging using nanobodies JO - Curr Opin Biotechnol VL - 22 UR - https://doi.org/10.1016/j.copbio.2011.06.009 DO - 10.1016/j.copbio.2011.06.009 ID - Vaneycken2011 ER - TY - JOUR AU - Castelli, M. S. AU - McGonigle, P. AU - Hornby, P. J. PY - 2019 DA - 2019// TI - The pharmacology and therapeutic applications of monoclonal antibodies JO - Pharmacol Res Perspect VL - 7 UR - https://doi.org/10.1002/prp2.535 DO - 10.1002/prp2.535 ID - Castelli2019 ER - TY - JOUR AU - Nejadmoghaddam, M. R. AU - Minai-Tehrani, A. AU - Ghahremanzadeh, R. AU - Mahmoudi, M. AU - Dinarvand, R. AU - Zarnani, A. H. PY - 2019 DA - 2019// TI - Antibody-drug conjugates: possibilities and challenges JO - Avicenna J Med Biotechnol VL - 11 ID - Nejadmoghaddam2019 ER - TY - JOUR AU - Harmsen, M. M. AU - Solt, C. B. AU - Fijten, H. P. PY - 2009 DA - 2009// TI - Enhancement of toxin- and virus-neutralizing capacity of single-domain antibody fragments by N-glycosylation JO - Appl Microbiol Biotechnol VL - 84 UR - https://doi.org/10.1007/s00253-009-2029-1 DO - 10.1007/s00253-009-2029-1 ID - Harmsen2009 ER - TY - JOUR AU - Pan, H. AU - Liu, J. AU - Deng, W. AU - Xing, J. AU - Li, Q. AU - Wang, Z. PY - 2018 DA - 2018// TI - Site-specific PEGylation of an anti-CEA/CD3 bispecific antibody improves its antitumor efficacy JO - Int J Nanomed VL - 13 UR - https://doi.org/10.2147/IJN.S164542 DO - 10.2147/IJN.S164542 ID - Pan2018 ER - TY - JOUR AU - Gainkam, L. O. AU - Caveliers, V. AU - Devoogdt, N. AU - Vanhove, C. AU - Xavier, C. AU - Boerman, O. PY - 2011 DA - 2011// TI - Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice JO - Contrast Media Mol Imaging VL - 6 UR - https://doi.org/10.1002/cmmi.408 DO - 10.1002/cmmi.408 ID - Gainkam2011 ER - TY - JOUR AU - D'Huyvetter, M. AU - Vincke, C. AU - Xavier, C. AU - Aerts, A. AU - Impens, N. AU - Baatout, S. PY - 2014 DA - 2014// TI - Targeted radionuclide therapy with A 177Lu-labeled anti-HER2 nanobody JO - Theranostics VL - 4 UR - https://doi.org/10.7150/thno.8156 DO - 10.7150/thno.8156 ID - D'Huyvetter2014 ER - TY - JOUR AU - Rousseau, E. AU - Lau, J. AU - Kuo, H. T. AU - Zhang, Z. AU - Merkens, H. AU - Hundal-Jabal, N. PY - 2018 DA - 2018// TI - Monosodium glutamate reduces (68)Ga-PSMA-11 Uptake in salivary glands and kidneys in a preclinical prostate cancer model JO - J Nucl Med VL - 59 UR - https://doi.org/10.2967/jnumed.118.215350 DO - 10.2967/jnumed.118.215350 ID - Rousseau2018 ER - TY - JOUR AU - Broek, B. AU - Devoogdt, N. AU - D'Hollander, A. AU - Gijs, H. L. AU - Jans, K. AU - Lagae, L. PY - 2011 DA - 2011// TI - Specific cell targeting with nanobody conjugated branched gold nanoparticles for photothermal therapy JO - ACS Nano VL - 5 UR - https://doi.org/10.1021/nn1023363 DO - 10.1021/nn1023363 ID - Broek2011 ER - TY - JOUR AU - Bannas, P. AU - Hambach, J. AU - Koch-Nolte, F. PY - 2017 DA - 2017// TI - Nanobodies and nanobody-based human heavy chain antibodies as antitumor therapeutics JO - Frontiers in immunology VL - 8 UR - https://doi.org/10.3389/fimmu.2017.01603 DO - 10.3389/fimmu.2017.01603 ID - Bannas2017 ER - TY - JOUR AU - Chakravarty, R. AU - Goel, S. AU - Cai, W. PY - 2014 DA - 2014// TI - Nanobody: the "magic bullet" for molecular imaging? JO - Theranostics VL - 4 UR - https://doi.org/10.7150/thno.8006 DO - 10.7150/thno.8006 ID - Chakravarty2014 ER - TY - JOUR AU - Vos, J. AU - Devoogdt, N. AU - Lahoutte, T. AU - Muyldermans, S. PY - 2013 DA - 2013// TI - Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target JO - Expert Opinion Biol Therapy VL - 13 UR - https://doi.org/10.1517/14712598.2013.800478 DO - 10.1517/14712598.2013.800478 ID - Vos2013 ER - TY - STD TI - Jung KH, Park JW, Lee JH, Lee EJ, Moon SH, Cho YS, et al. (89)Zr Labeled anti-PD-L1 antibody PET monitors gemcitabine therapy-induced modulation of tumor PD-L1 expression. J Nuclear Med. 2020. ID - ref25 ER - TY - JOUR AU - Huang, L. AU - Gainkam, L. O. AU - Caveliers, V. AU - Vanhove, C. AU - Keyaerts, M. AU - Baetselier, P. PY - 2008 DA - 2008// TI - SPECT imaging with 99mTc-labeled EGFR-specific nanobody for in vivo monitoring of EGFR expression JO - Mol Imaging Biol VL - 10 UR - https://doi.org/10.1007/s11307-008-0133-8 DO - 10.1007/s11307-008-0133-8 ID - Huang2008 ER - TY - STD TI - Leung K. (68)Ga-Desferrioxamine p-isothiocyanatobenzyl-anti-EGFR nanobody 7D12. Molecular Imaging and Contrast Agent Database (MICAD). Bethesda (MD): National Center for Biotechnology Information (US); 2004. ID - ref27 ER - TY - JOUR AU - Piramoon, M. AU - Hosseinimehr, S. J. AU - Omidfar, K. AU - Noaparast, Z. AU - Abedi, S. M. PY - 2017 DA - 2017// TI - (99m) Tc-anti-epidermal growth factor receptor nanobody for tumor imaging JO - Chem Biol Drug Des VL - 89 UR - https://doi.org/10.1111/cbdd.12871 DO - 10.1111/cbdd.12871 ID - Piramoon2017 ER - TY - JOUR AU - Omidfar, K. AU - Amjad Zanjani, F. S. AU - Hagh, A. G. AU - Azizi, M. D. AU - Rasouli, S. J. AU - Kashanian, S. PY - 2013 DA - 2013// TI - Efficient growth inhibition of EGFR over-expressing tumor cells by an anti-EGFR nanobody JO - Mol Biol Rep VL - 40 UR - https://doi.org/10.1007/s11033-013-2790-1 DO - 10.1007/s11033-013-2790-1 ID - Omidfar2013 ER - TY - JOUR AU - Xavier, C. AU - Blykers, A. AU - Vaneycken, I. AU - D'Huyvetter, M. AU - Heemskerk, J. AU - Lahoutte, T. PY - 2016 DA - 2016// TI - (18)F-nanobody for PET imaging of HER2 overexpressing tumors JO - Nucl Med Biol VL - 43 UR - https://doi.org/10.1016/j.nucmedbio.2016.01.002 DO - 10.1016/j.nucmedbio.2016.01.002 ID - Xavier2016 ER - TY - JOUR AU - Keyaerts, M. AU - Xavier, C. AU - Heemskerk, J. AU - Devoogdt, N. AU - Everaert, H. AU - Ackaert, C. PY - 2016 DA - 2016// TI - Phase I Study of 68Ga-HER2-Nanobody for PET/CT Assessment of HER2 Expression in Breast Carcinoma JO - J Nucl Med VL - 57 UR - https://doi.org/10.2967/jnumed.115.162024 DO - 10.2967/jnumed.115.162024 ID - Keyaerts2016 ER - TY - JOUR AU - Xavier, C. AU - Vaneycken, I. AU - D'Huyvetter, M. AU - Heemskerk, J. AU - Keyaerts, M. AU - Vincke, C. PY - 2013 DA - 2013// TI - Synthesis, preclinical validation, dosimetry, and toxicity of 68Ga-NOTA-anti-HER2 nanobodies for iPET imaging of HER2 receptor expression in cancer JO - J Nuclear Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.111021 DO - 10.2967/jnumed.112.111021 ID - Xavier2013 ER - TY - JOUR AU - Kijanka, M. AU - Warnders, F. J. AU - Khattabi, M. AU - Lub-de Hooge, M. AU - Dam, G. M. AU - Ntziachristos, V. PY - 2013 DA - 2013// TI - Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery JO - Eur J Nuclear Med Mol Imaging VL - 40 UR - https://doi.org/10.1007/s00259-013-2471-2 DO - 10.1007/s00259-013-2471-2 ID - Kijanka2013 ER - TY - STD TI - Warnders FJ, Terwisscha van Scheltinga AGT, Knuehl C, van Roy M, de Vries EFJ, Kosterink JGW, et al. Human epidermal growth factor receptor 3-specific tumor uptake and biodistribution of (89)Zr-MSB0010853 visualized by real-time and noninvasive PET imaging. J Nucl Med. 2017;58(8):1210–5. ID - ref34 ER - TY - JOUR AU - Vosjan, M. J. AU - Vercammen, J. AU - Kolkman, J. A. AU - Stigter-van Walsum, M. AU - Revets, H. AU - Dongen, G. A. PY - 2012 DA - 2012// TI - Nanobodies targeting the hepatocyte growth factor: potential new drugs for molecular cancer therapy JO - Mol Cancer Ther VL - 11 UR - https://doi.org/10.1158/1535-7163.MCT-11-0891 DO - 10.1158/1535-7163.MCT-11-0891 ID - Vosjan2012 ER - TY - JOUR AU - Ramos-Gomes, F. AU - Bode, J. AU - Sukhanova, A. AU - Bozrova, S. V. AU - Saccomano, M. AU - Mitkovski, M. PY - 2018 DA - 2018// TI - Single- and two-photon imaging of human micrometastases and disseminated tumour cells with conjugates of nanobodies and quantum dots JO - Sci Rep VL - 8 UR - https://doi.org/10.1038/s41598-018-22973-8 DO - 10.1038/s41598-018-22973-8 ID - Ramos-Gomes2018 ER - TY - JOUR AU - Meyer, T. AU - Muyldermans, S. AU - Depicker, A. PY - 2014 DA - 2014// TI - Nanobody-based products as research and diagnostic tools JO - Trends Biotechnol VL - 32 UR - https://doi.org/10.1016/j.tibtech.2014.03.001 DO - 10.1016/j.tibtech.2014.03.001 ID - Meyer2014 ER - TY - JOUR AU - Zhang, F. AU - Wei, H. AU - Wang, X. AU - Bai, Y. AU - Wang, P. AU - Wu, J. PY - 2017 DA - 2017// TI - Structural basis of a novel PD-L1 nanobody for immune checkpoint blockade JO - Cell Discovery VL - 3 UR - https://doi.org/10.1038/celldisc.2017.4 DO - 10.1038/celldisc.2017.4 ID - Zhang2017 ER - TY - JOUR AU - Li, D. AU - Cheng, S. AU - Zou, S. AU - Zhu, D. AU - Zhu, T. AU - Wang, P. PY - 2018 DA - 2018// TI - Immuno-PET imaging of (89)Zr labeled anti-PD-L1 domain antibody JO - Mol Pharm VL - 15 UR - https://doi.org/10.1021/acs.molpharmaceut.8b00062 DO - 10.1021/acs.molpharmaceut.8b00062 ID - Li2018 ER - TY - JOUR AU - Li, D. AU - Zou, S. AU - Cheng, S. AU - Song, S. AU - Wang, P. AU - Zhu, X. PY - 2019 DA - 2019// TI - Monitoring the response of PD-L1 expression to epidermal growth factor receptor tyrosine kinase inhibitors in nonsmall-cell lung cancer xenografts by immuno-PET imaging JO - Mol Pharm VL - 16 UR - https://doi.org/10.1021/acs.molpharmaceut.9b00307 DO - 10.1021/acs.molpharmaceut.9b00307 ID - Li2019 ER - TY - JOUR AU - Brussel, A. S. AU - Adams, A. AU - Oliveira, S. AU - Dorresteijn, B. AU - Khattabi, M. AU - Vermeulen, J. F. PY - 2016 DA - 2016// TI - Hypoxia-targeting fluorescent nanobodies for optical molecular imaging of pre-invasive breast cancer JO - Mol Imaging Biol VL - 18 UR - https://doi.org/10.1007/s11307-015-0909-6 DO - 10.1007/s11307-015-0909-6 ID - Brussel2016 ER - TY - JOUR AU - Blykers, A. AU - Schoonooghe, S. AU - Xavier, C. AU - D'Hoe, K. AU - Laoui, D. AU - D'Huyvetter, M. PY - 2015 DA - 2015// TI - PET imaging of macrophage mannose receptor-expressing macrophages in tumor stroma using 18f-radiolabeled camelid single-domain antibody fragments JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.115.156828 DO - 10.2967/jnumed.115.156828 ID - Blykers2015 ER - TY - JOUR AU - Bala, G. AU - Baudhuin, H. AU - Remory, I. AU - Gillis, K. AU - Debie, P. AU - Krasniqi, A. PY - 2018 DA - 2018// TI - Evaluation of [(99m)Tc]radiolabeled macrophage mannose receptor-specific nanobodies for targeting of atherosclerotic lesions in mice JO - Mol Imaging Biol VL - 20 UR - https://doi.org/10.1007/s11307-017-1117-3 DO - 10.1007/s11307-017-1117-3 ID - Bala2018 ER - TY - JOUR AU - Varasteh, Z. AU - Mohanta, S. AU - Li, Y. AU - Lopez Armbruster, N. AU - Braeuer, M. AU - Nekolla, S. G. PY - 2019 DA - 2019// TI - Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using (68)Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques JO - EJNMMI Res VL - 9 UR - https://doi.org/10.1186/s13550-019-0474-0 DO - 10.1186/s13550-019-0474-0 ID - Varasteh2019 ER - TY - JOUR AU - Broisat, A. AU - Hernot, S. AU - Toczek, J. AU - Vos, J. AU - Riou, L. M. AU - Martin, S. PY - 2012 DA - 2012// TI - Nanobodies targeting mouse/human VCAM1 for the nuclear imaging of atherosclerotic lesions JO - Circ Res VL - 110 UR - https://doi.org/10.1161/CIRCRESAHA.112.265140 DO - 10.1161/CIRCRESAHA.112.265140 ID - Broisat2012 ER - TY - JOUR AU - Bala, G. AU - Crauwels, M. AU - Blykers, A. AU - Remory, I. AU - Marschall, A. L. J. AU - Dübel, S. PY - 2019 DA - 2019// TI - Radiometal-labeled anti-VCAM-1 nanobodies as molecular tracers for atherosclerosis - impact of radiochemistry on pharmacokinetics JO - Biol Chem VL - 400 UR - https://doi.org/10.1515/hsz-2018-0330 DO - 10.1515/hsz-2018-0330 ID - Bala2019 ER - TY - JOUR AU - Zheng, F. AU - Put, S. AU - Bouwens, L. AU - Lahoutte, T. AU - Matthys, P. AU - Muyldermans, S. PY - 2014 DA - 2014// TI - Molecular imaging with macrophage CRIg-targeting nanobodies for early and preclinical diagnosis in a mouse model of rheumatoid arthritis JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.130617 DO - 10.2967/jnumed.113.130617 ID - Zheng2014 ER - TY - JOUR AU - Diakos, C. I. AU - Charles, K. A. AU - McMillan, D. C. AU - Clarke, S. J. PY - 2014 DA - 2014// TI - Cancer-related inflammation and treatment effectiveness JO - Lancet Oncol VL - 15 UR - https://doi.org/10.1016/S1470-2045(14)70263-3 DO - 10.1016/S1470-2045(14)70263-3 ID - Diakos2014 ER - TY - JOUR AU - Mantovani, A. AU - Allavena, P. AU - Sica, A. AU - Balkwill, F. PY - 2008 DA - 2008// TI - Cancer-related inflammation JO - Nature VL - 454 UR - https://doi.org/10.1038/nature07205 DO - 10.1038/nature07205 ID - Mantovani2008 ER - TY - JOUR AU - Franklin, R. A. AU - Liao, W. AU - Sarkar, A. AU - Kim, M. V. AU - Bivona, M. R. AU - Liu, K. PY - 2014 DA - 2014// TI - The cellular and molecular origin of tumor-associated macrophages JO - Science VL - 344 UR - https://doi.org/10.1126/science.1252510 DO - 10.1126/science.1252510 ID - Franklin2014 ER - TY - JOUR AU - Kim, J. AU - Bae, J. S. PY - 2016 DA - 2016// TI - Tumor-associated macrophages and neutrophils in tumor microenvironment JO - Mediators Inflamm VL - 2016 ID - Kim2016 ER - TY - JOUR AU - Movahedi, K. AU - Schoonooghe, S. AU - Laoui, D. AU - Houbracken, I. AU - Waelput, W. AU - Breckpot, K. PY - 2012 DA - 2012// TI - Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages JO - Can Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-2994 DO - 10.1158/0008-5472.CAN-11-2994 ID - Movahedi2012 ER - TY - JOUR AU - Pyonteck, S. M. AU - Akkari, L. AU - Schuhmacher, A. J. AU - Bowman, R. L. AU - Sevenich, L. AU - Quail, D. F. PY - 2013 DA - 2013// TI - CSF-1R inhibition alters macrophage polarization and blocks glioma progression JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3337 DO - 10.1038/nm.3337 ID - Pyonteck2013 ER - TY - JOUR AU - Ries, C. H. AU - Cannarile, M. A. AU - Hoves, S. AU - Benz, J. AU - Wartha, K. AU - Runza, V. PY - 2014 DA - 2014// TI - Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy JO - Cancer Cell VL - 25 UR - https://doi.org/10.1016/j.ccr.2014.05.016 DO - 10.1016/j.ccr.2014.05.016 ID - Ries2014 ER - TY - JOUR AU - Cannarile, M. A. AU - Weisser, M. AU - Jacob, W. AU - Jegg, A. M. AU - Ries, C. H. AU - Rüttinger, D. PY - 2017 DA - 2017// TI - Colony-stimulating factor 1 receptor (CSF1R) inhibitors in cancer therapy JO - J Immunother Cancer VL - 5 UR - https://doi.org/10.1186/s40425-017-0257-y DO - 10.1186/s40425-017-0257-y ID - Cannarile2017 ER - TY - JOUR AU - Libby, P. PY - 2012 DA - 2012// TI - Inflammation in atherosclerosis JO - Arterioscler Thromb Vasc Biol VL - 32 UR - https://doi.org/10.1161/ATVBAHA.108.179705 DO - 10.1161/ATVBAHA.108.179705 ID - Libby2012 ER - TY - STD TI - Senders ML, Hernot S, Carlucci G, van de Voort JC, Fay F, Calcagno C, et al. Nanobody-facilitated multiparametric PET/MRI phenotyping of atherosclerosis. JACC Cardiovasc Imaging. 2018. ID - ref57 ER - TY - JOUR AU - Swirski, F. K. AU - Nahrendorf, M. PY - 2013 DA - 2013// TI - Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure JO - Science (New York, NY) VL - 339 UR - https://doi.org/10.1126/science.1230719 DO - 10.1126/science.1230719 ID - Swirski2013 ER - TY - JOUR AU - Bala, G. AU - Blykers, A. AU - Xavier, C. AU - Descamps, B. AU - Broisat, A. AU - Ghezzi, C. PY - 2016 DA - 2016// TI - Targeting of vascular cell adhesion molecule-1 by 18F-labelled nanobodies for PET/CT imaging of inflamed atherosclerotic plaques JO - European heart journal cardiovascular Imaging VL - 17 UR - https://doi.org/10.1093/ehjci/jev346 DO - 10.1093/ehjci/jev346 ID - Bala2016 ER - TY - STD TI - Bridoux J, Neyt S, Debie P, Descamps B, Devoogdt N, Cleeren F, et al. Improved detection of molecular markers of atherosclerotic plaques using sub-millimeter PET imaging. Molecules (Basel, Switzerland). 2020;25(8). ID - ref60 ER - TY - JOUR AU - Cybulsky, M. I. AU - Iiyama, K. AU - Li, H. AU - Zhu, S. AU - Chen, M. AU - Iiyama, M. PY - 2001 DA - 2001// TI - A major role for VCAM-1, but not ICAM-1, in early atherosclerosis JO - J Clin Investig VL - 107 UR - https://doi.org/10.1172/JCI11871 DO - 10.1172/JCI11871 ID - Cybulsky2001 ER - TY - STD TI - Thayse K, Kindt N, Laurent S, Carlier S. VCAM-1 target in non-invasive imaging for the detection of atherosclerotic plaques. Biology. 2020;9(11). ID - ref62 ER - TY - STD TI - Kong DH, Kim YK, Kim MR, Jang JH, Lee S. Emerging roles of vascular cell adhesion molecule-1 (VCAM-1) in immunological disorders and cancer. Int J Mol Sci. 2018;19(4). ID - ref63 ER - TY - JOUR AU - Zheng, F. AU - Devoogdt, N. AU - Sparkes, A. AU - Morias, Y. AU - Abels, C. AU - Stijlemans, B. PY - 2015 DA - 2015// TI - Monitoring liver macrophages using nanobodies targeting Vsig4: concanavalin A induced acute hepatitis as paradigm JO - Immunobiology VL - 220 UR - https://doi.org/10.1016/j.imbio.2014.09.018 DO - 10.1016/j.imbio.2014.09.018 ID - Zheng2015 ER - TY - JOUR AU - Zheng, F. AU - Sparkes, A. AU - Baetselier, P. AU - Schoonooghe, S. AU - Stijlemans, B. AU - Muyldermans, S. PY - 2017 DA - 2017// TI - Molecular Imaging with Kupffer cell-targeting nanobodies for diagnosis and prognosis in mouse models of liver pathogenesis JO - Mol Imaging Biol VL - 19 UR - https://doi.org/10.1007/s11307-016-0976-3 DO - 10.1007/s11307-016-0976-3 ID - Zheng2017 ER - TY - JOUR AU - Homet Moreno, B. AU - Ribas, A. PY - 2015 DA - 2015// TI - Anti-programmed cell death protein-1/ligand-1 therapy in different cancers JO - Br J Cancer VL - 112 UR - https://doi.org/10.1038/bjc.2015.124 DO - 10.1038/bjc.2015.124 ID - Homet Moreno2015 ER - TY - JOUR AU - Patel, S. P. AU - Kurzrock, R. PY - 2015 DA - 2015// TI - PD-L1 Expression as a predictive biomarker in cancer immunotherapy JO - Mol Cancer Ther VL - 14 UR - https://doi.org/10.1158/1535-7163.MCT-14-0983 DO - 10.1158/1535-7163.MCT-14-0983 ID - Patel2015 ER - TY - STD TI - Papadopoulos KP, Harb W, Lu N, Ma X, He Y, Yuan L, et al. Phase I study of KN035, a novel fusion Anti-PD-L1 antibody administered subcutaneously in patients with advanced solid tumors in the USA. Ann Oncol 2018;29 Suppl 8:viii405. ID - ref68 ER - TY - STD TI - Lv G, Qiu L, Sun Y, Li K, Liu Q, Zhao Q, et al. PET imaging of tumor PD-L1 expression with a highly specific non-blocking nanobody. J Nuclear Med. 2019. ID - ref69 ER - TY - JOUR AU - Semenza, G. L. PY - 2003 DA - 2003// TI - Targeting HIF-1 for cancer therapy JO - Nat Rev Cancer VL - 3 UR - https://doi.org/10.1038/nrc1187 DO - 10.1038/nrc1187 ID - Semenza2003 ER - TY - JOUR AU - Pastorekova, S. AU - Gillies, R. J. PY - 2019 DA - 2019// TI - The role of carbonic anhydrase IX in cancer development: links to hypoxia, acidosis, and beyond JO - Cancer Metastasis Rev VL - 38 UR - https://doi.org/10.1007/s10555-019-09799-0 DO - 10.1007/s10555-019-09799-0 ID - Pastorekova2019 ER - TY - JOUR AU - McDonald, P. C. AU - Dedhar, S. PY - 2014 DA - 2014// TI - Carbonic anhydrase IX (CAIX) as a mediator of hypoxia-induced stress response in cancer cells JO - Sub-cellular Biochem VL - 75 UR - https://doi.org/10.1007/978-94-007-7359-2_13 DO - 10.1007/978-94-007-7359-2_13 ID - McDonald2014 ER - TY - STD TI - Kijanka MM, van Brussel AS, van der Wall E, Mali WP, van Diest PJ, van Bergen En Henegouwen PM, et al. Optical imaging of pre-invasive breast cancer with a combination of VHHs targeting CAIX and HER2 increases contrast and facilitates tumour characterization. EJNMMI Res. 2016;6(1):14. ID - ref73 ER - TY - JOUR AU - Menzel, S. AU - Schwarz, N. AU - Haag, F. AU - Koch-Nolte, F. PY - 2018 DA - 2018// TI - Nanobody-based biologics for modulating purinergic signaling in inflammation and immunity JO - Front Pharmacol VL - 9 UR - https://doi.org/10.3389/fphar.2018.00266 DO - 10.3389/fphar.2018.00266 ID - Menzel2018 ER - TY - STD TI - Verhaar ER, Woodham AW, Ploegh HL. Nanobodies in cancer. Seminars in immunology. 2020:101425. ID - ref75 ER - TY - STD TI - Bakhtiari SH, Rahbarizadeh F, Hasannia S, Ahmadvand D, Iri-Sofla FJ, Rasaee MJ. Anti-MUC1 nanobody can redirect T-body cytotoxic effector function. Hybridoma (2005). 2009;28(2):85–92. ID - ref76 ER - TY - JOUR AU - Duggan, S. PY - 2018 DA - 2018// TI - Caplacizumab: first global approval JO - Drugs VL - 78 UR - https://doi.org/10.1007/s40265-018-0989-0 DO - 10.1007/s40265-018-0989-0 ID - Duggan2018 ER - TY - JOUR AU - Morrison, C. PY - 2019 DA - 2019// TI - Nanobody approval gives domain antibodies a boost JO - Nat Rev Drug Discovery VL - 18 UR - https://doi.org/10.1038/d41573-019-00104-w DO - 10.1038/d41573-019-00104-w ID - Morrison2019 ER - TY - STD TI - Sampath S. Treatment: radiation therapy. Cancer Treatment Res. 2016;170:105–18. ID - ref79 ER - TY - JOUR AU - Sgouros, G. AU - Bodei, L. AU - McDevitt, M. R. AU - Nedrow, J. R. PY - 2020 DA - 2020// TI - Radiopharmaceutical therapy in cancer: clinical advances and challenges JO - Nat Rev Drug Discovery VL - 19 UR - https://doi.org/10.1038/s41573-020-0073-9 DO - 10.1038/s41573-020-0073-9 ID - Sgouros2020 ER - TY - JOUR AU - Jadvar, H. PY - 2017 DA - 2017// TI - Targeted radionuclide therapy: an evolution toward precision cancer treatment JO - AJR Am J Roentgenol VL - 209 UR - https://doi.org/10.2214/AJR.17.18264 DO - 10.2214/AJR.17.18264 ID - Jadvar2017 ER - TY - JOUR AU - Kumar, C. AU - Shetake, N. AU - Desai, S. AU - Kumar, A. AU - Samuel, G. AU - Pandey, B. N. PY - 2016 DA - 2016// TI - Relevance of radiobiological concepts in radionuclide therapy of cancer JO - Int J Radiat Biol VL - 92 UR - https://doi.org/10.3109/09553002.2016.1144944 DO - 10.3109/09553002.2016.1144944 ID - Kumar2016 ER - TY - JOUR AU - Dekempeneer, Y. AU - Keyaerts, M. AU - Krasniqi, A. AU - Puttemans, J. AU - Muyldermans, S. AU - Lahoutte, T. PY - 2016 DA - 2016// TI - Targeted alpha therapy using short-lived alpha-particles and the promise of nanobodies as targeting vehicle JO - Expert Opinion Biol Ther VL - 16 UR - https://doi.org/10.1080/14712598.2016.1185412 DO - 10.1080/14712598.2016.1185412 ID - Dekempeneer2016 ER - TY - JOUR AU - D'Huyvetter, M. AU - Vos, J. AU - Xavier, C. AU - Pruszynski, M. AU - Sterckx, Y. G. J. AU - Massa, S. PY - 2017 DA - 2017// TI - (131)I-labeled anti-HER2 camelid sdAb as a theranostic tool in cancer treatment JO - Clin Cancer VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-17-0310 DO - 10.1158/1078-0432.CCR-17-0310 ID - D'Huyvetter2017 ER - TY - JOUR AU - Pruszynski, M. AU - D'Huyvetter, M. AU - Bruchertseifer, F. AU - Morgenstern, A. AU - Lahoutte, T. PY - 2018 DA - 2018// TI - Evaluation of an anti-HER2 nanobody labeled with (225)Ac for targeted alpha-particle therapy of cancer JO - Mol Pharm VL - 15 UR - https://doi.org/10.1021/acs.molpharmaceut.7b00985 DO - 10.1021/acs.molpharmaceut.7b00985 ID - Pruszynski2018 ER - TY - JOUR AU - Pruszynski, M. AU - Koumarianou, E. AU - Vaidyanathan, G. AU - Revets, H. AU - Devoogdt, N. AU - Lahoutte, T. PY - 2014 DA - 2014// TI - Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling JO - J Nucl Med VL - 55 UR - https://doi.org/10.2967/jnumed.113.127100 DO - 10.2967/jnumed.113.127100 ID - Pruszynski2014 ER - TY - JOUR AU - Iqbal, J. AU - Anwar, F. AU - Afridi, S. PY - 2017 DA - 2017// TI - Targeted drug delivery systems and their therapeutic applications in cancer and immune pathological conditions JO - Infect Disord Drug Targets VL - 17 UR - https://doi.org/10.2174/1871526517666170606102623 DO - 10.2174/1871526517666170606102623 ID - Iqbal2017 ER - TY - STD TI - Altintas I, Heukers R, van der Meel R, Lacombe M, Amidi M, van Bergen En Henegouwen PM, et al. Nanobody-albumin nanoparticles (NANAPs) for the delivery of a multikinase inhibitor 17864 to EGFR overexpressing tumor cells. J Controlled Release. 2013;165(2):110–8. ID - ref88 ER - TY - JOUR AU - Talelli, M. AU - Oliveira, S. AU - Rijcken, C. J. AU - Pieters, E. H. AU - Etrych, T. AU - Ulbrich, K. PY - 2013 DA - 2013// TI - Intrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapy JO - Biomaterials VL - 34 UR - https://doi.org/10.1016/j.biomaterials.2012.09.064 DO - 10.1016/j.biomaterials.2012.09.064 ID - Talelli2013 ER - TY - STD TI - Heukers R, van Bergen en Henegouwen PM, Oliveira S. Nanobody-photosensitizer conjugates for targeted photodynamic therapy. Nanomedicine. 2014;10(7):1441–51. ID - ref90 ER - TY - STD TI - Oliveira S, Schiffelers RM, van der Veeken J, van der Meel R, Vongpromek R, van Bergen En Henegouwen PM, et al. Downregulation of EGFR by a novel multivalent nanobody-liposome platform. J Controlled Release. 2010;145(2):165–75. ID - ref91 ER - TY - JOUR AU - Meel, R. AU - Oliveira, S. AU - Altintas, I. AU - Haselberg, R. AU - Veeken, J. AU - Roovers, R. C. PY - 2012 DA - 2012// TI - Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment JO - J Controlled Release VL - 159 UR - https://doi.org/10.1016/j.jconrel.2011.12.027 DO - 10.1016/j.jconrel.2011.12.027 ID - Meel2012 ER - TY - JOUR AU - Driel, P. AU - Boonstra, M. C. AU - Slooter, M. D. AU - Heukers, R. AU - Stammes, M. A. AU - Snoeks, T. J. A. PY - 2016 DA - 2016// TI - EGFR targeted nanobody-photosensitizer conjugates for photodynamic therapy in a pre-clinical model of head and neck cancer JO - J Controlled Release VL - 229 UR - https://doi.org/10.1016/j.jconrel.2016.03.014 DO - 10.1016/j.jconrel.2016.03.014 ID - Driel2016 ER - TY - JOUR AU - Dickers, K. J. AU - Bradberry, S. M. AU - Rice, P. AU - Griffiths, G. D. AU - Vale, J. A. PY - 2003 DA - 2003// TI - Abrin poisoning JO - Toxicol Rev VL - 22 UR - https://doi.org/10.2165/00139709-200322030-00002 DO - 10.2165/00139709-200322030-00002 ID - Dickers2003 ER - TY - JOUR AU - Audi, J. AU - Belson, M. AU - Patel, M. AU - Schier, J. AU - Osterloh, J. PY - 2005 DA - 2005// TI - Ricin poisoning: a comprehensive review JO - JAMA VL - 294 UR - https://doi.org/10.1001/jama.294.18.2342 DO - 10.1001/jama.294.18.2342 ID - Audi2005 ER - TY - JOUR AU - Ham, S. AU - Min, K. A. AU - Yang, J. W. AU - Shin, M. C. PY - 2017 DA - 2017// TI - Fusion of gelonin and anti-insulin-like growth factor-1 receptor (IGF-1R) affibody for enhanced brain cancer therapy JO - Arch Pharmacal Res VL - 40 UR - https://doi.org/10.1007/s12272-017-0953-7 DO - 10.1007/s12272-017-0953-7 ID - Ham2017 ER - TY - STD TI - Leshem Y, Pastan I. Pseudomonas Exotoxin immunotoxins and anti-tumor immunity: from observations at the patient's bedside to evaluation in preclinical models. Toxins. 2019;11(1). ID - ref97 ER - TY - JOUR AU - Li, Y. M. AU - Vallera, D. A. AU - Hall, W. A. PY - 2013 DA - 2013// TI - Diphtheria toxin-based targeted toxin therapy for brain tumors JO - J Neurooncol VL - 114 UR - https://doi.org/10.1007/s11060-013-1157-8 DO - 10.1007/s11060-013-1157-8 ID - Li2013 ER - TY - JOUR AU - Pirker, R. PY - 1988 DA - 1988// TI - Immunotoxins against solid tumors JO - J Cancer Res Clin Oncol VL - 114 UR - https://doi.org/10.1007/BF02128183 DO - 10.1007/BF02128183 ID - Pirker1988 ER - TY - JOUR AU - Sempowski, G. D. AU - Lee, D. M. AU - Kaufman, R. E. AU - Haynes, B. F. PY - 1999 DA - 1999// TI - Structure and function of the CD7 molecule JO - Crit Rev Immunol VL - 19 ID - Sempowski1999 ER - TY - JOUR AU - Tang, J. AU - Li, J. AU - Zhu, X. AU - Yu, Y. AU - Chen, D. AU - Yuan, L. PY - 2016 DA - 2016// TI - Novel CD7-specific nanobody-based immunotoxins potently enhanced apoptosis of CD7-positive malignant cells JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.8710 DO - 10.18632/oncotarget.8710 ID - Tang2016 ER - TY - JOUR AU - Yu, Y. AU - Li, J. AU - Zhu, X. AU - Tang, X. AU - Bao, Y. AU - Sun, X. PY - 2017 DA - 2017// TI - Humanized CD7 nanobody-based immunotoxins exhibit promising anti-T-cell acute lymphoblastic leukemia potential JO - Int J Nanomed VL - 12 UR - https://doi.org/10.2147/IJN.S127575 DO - 10.2147/IJN.S127575 ID - Yu2017 ER - TY - JOUR AU - Bobkov, V. AU - Zarca, A. M. AU - Hout, A. AU - Arimont, M. AU - Doijen, J. AU - Bialkowska, M. PY - 2018 DA - 2018// TI - Nanobody-Fc constructs targeting chemokine receptor CXCR4 potently inhibit signaling and CXCR4-mediated HIV-entry and induce antibody effector functions JO - Biochem Pharmacol VL - 158 UR - https://doi.org/10.1016/j.bcp.2018.10.014 DO - 10.1016/j.bcp.2018.10.014 ID - Bobkov2018 ER - TY - JOUR AU - Li, J. AU - Zhou, C. AU - Dong, B. AU - Zhong, H. AU - Chen, S. AU - Li, Q. PY - 2016 DA - 2016// TI - Single domain antibody-based bispecific antibody induces potent specific anti-tumor activity JO - Cancer Biol Ther VL - 17 UR - https://doi.org/10.1080/15384047.2016.1235659 DO - 10.1080/15384047.2016.1235659 ID - Li2016 ER - TY - JOUR AU - Liu, Y. AU - Wang, Y. AU - Xing, J. AU - Li, Y. AU - Liu, J. AU - Wang, Z. PY - 2018 DA - 2018// TI - A novel multifunctional anti-CEA-IL15 molecule displays potent antitumor activities JO - Drug Des Dev Ther VL - 12 UR - https://doi.org/10.2147/DDDT.S166373 DO - 10.2147/DDDT.S166373 ID - Liu2018 ER - TY - JOUR AU - Fang, T. AU - Li, R. AU - Li, Z. AU - Cho, J. AU - Guzman, J. S. AU - Kamm, R. D. PY - 2019 DA - 2019// TI - Remodeling of the tumor microenvironment by a chemokine/anti-PD-L1 nanobody fusion protein JO - Mol Pharm VL - 16 UR - https://doi.org/10.1021/acs.molpharmaceut.9b00078 DO - 10.1021/acs.molpharmaceut.9b00078 ID - Fang2019 ER - TY - JOUR AU - Ries, J. AU - Kaplan, C. AU - Platonova, E. AU - Eghlidi, H. AU - Ewers, H. PY - 2012 DA - 2012// TI - A simple, versatile method for GFP-based super-resolution microscopy via nanobodies JO - Nat Methods VL - 9 UR - https://doi.org/10.1038/nmeth.1991 DO - 10.1038/nmeth.1991 ID - Ries2012 ER - TY - JOUR AU - Leduc, C. AU - Si, S. AU - Gautier, J. AU - Soto-Ribeiro, M. AU - Wehrle-Haller, B. AU - Gautreau, A. PY - 2013 DA - 2013// TI - A highly specific gold nanoprobe for live-cell single-molecule imaging JO - Nano Lett VL - 13 UR - https://doi.org/10.1021/nl304561g DO - 10.1021/nl304561g ID - Leduc2013 ER - TY - JOUR AU - Virant, D. AU - Traenkle, B. AU - Maier, J. AU - Kaiser, P. D. AU - Bodenhofer, M. AU - Schmees, C. PY - 2018 DA - 2018// TI - A peptide tag-specific nanobody enables high-quality labeling for dSTORM imaging JO - Nat Commun VL - 9 UR - https://doi.org/10.1038/s41467-018-03191-2 DO - 10.1038/s41467-018-03191-2 ID - Virant2018 ER - TY - JOUR AU - Fang, T. AU - Lu, X. AU - Berger, D. AU - Gmeiner, C. AU - Cho, J. AU - Schalek, R. PY - 2018 DA - 2018// TI - Nanobody immunostaining for correlated light and electron microscopy with preservation of ultrastructure JO - Nat Methods VL - 15 UR - https://doi.org/10.1038/s41592-018-0177-x DO - 10.1038/s41592-018-0177-x ID - Fang2018 ER - TY - JOUR AU - Moradi, A. AU - Pourseif, M. M. AU - Jafari, B. AU - Parvizpour, S. AU - Omidi, Y. PY - 2020 DA - 2020// TI - Nanobody-based therapeutics against colorectal cancer: Precision therapies based on the personal mutanome profile and tumor neoantigens JO - Pharmacol Res VL - 156 UR - https://doi.org/10.1016/j.phrs.2020.104790 DO - 10.1016/j.phrs.2020.104790 ID - Moradi2020 ER - TY - JOUR AU - Goyvaerts, C. AU - Groeve, K. AU - Dingemans, J. AU - Lint, S. AU - Robays, L. AU - Heirman, C. PY - 2012 DA - 2012// TI - Development of the nanobody display technology to target lentiviral vectors to antigen-presenting cells JO - Gene Ther VL - 19 UR - https://doi.org/10.1038/gt.2011.206 DO - 10.1038/gt.2011.206 ID - Goyvaerts2012 ER - TY - JOUR AU - Lee, D. W. AU - Kochenderfer, J. N. AU - Stetler-Stevenson, M. AU - Cui, Y. K. AU - Delbrook, C. AU - Feldman, S. A. PY - 2015 DA - 2015// TI - T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial JO - Lancet (London, England) VL - 385 UR - https://doi.org/10.1016/S0140-6736(14)61403-3 DO - 10.1016/S0140-6736(14)61403-3 ID - Lee2015 ER - TY - JOUR AU - An, N. AU - Hou, Y. N. AU - Zhang, Q. X. AU - Li, T. AU - Zhang, Q. L. AU - Fang, C. PY - 2018 DA - 2018// TI - Anti-multiple myeloma activity of nanobody-based anti-CD38 chimeric antigen receptor T cells JO - Mol Pharm VL - 15 UR - https://doi.org/10.1021/acs.molpharmaceut.8b00584 DO - 10.1021/acs.molpharmaceut.8b00584 ID - An2018 ER -